Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yousef Katib

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biologics : Targets & Therapy|February 13, 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour MicroenvironmentMaher Kurdi, Nasser Mulla, Yousef Katib, et al.
World Journal of Oncology|July 15, 2022
Association Between CD204-Expressed Tumor-Associated Macrophages and <i>MGMT</i>-Promoter Methylation in the Microenvironment of Grade 4 AstrocytomasMaher Kurdi, Yousef Katib, Eyad Faizo, et al.
Cancers|February 4, 2021
Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative ReviewAhmad Chaddad, Michael J Kucharczyk, Abbas Cheddad, et al.
Cureus|January 30, 2023
Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center StudyAmber Hassan, Shadi Alahmadi, Omer Waqas, et al.
Pathology, Research and Practice|January 19, 2024
The effect of p53 on the activity of NRF2 and NDRG2 genes through apoptotic pathway in IDH-wildtype glioblastomaMaher Kurdi, Saleh Baeesa, Motaz M Fadul, et al.
Folia Neuropathologica|August 11, 2022
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinomaRiffat Mehboob, Maher Kurdi, Saleh Baeesa, et al.
Journal of Neuro-Oncology|July 4, 2023
Dynamic interplay between corticosteroid treatment and the role of SRC-1 gene dysregulation in the progression of WHO-Grade 4 AstrocytomaMaher Kurdi, Motaz M Fadul, Bassam M J Addas, et al.
Pathology, Research and Practice|September 19, 2023
Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failureNadeem S Butt, Maher Kurdi, Motaz M Fadul, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biologics : Targets & Therapy|February 13, 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour MicroenvironmentMaher Kurdi, Nasser Mulla, Yousef Katib, et al.
World Journal of Oncology|July 15, 2022
Association Between CD204-Expressed Tumor-Associated Macrophages and <i>MGMT</i>-Promoter Methylation in the Microenvironment of Grade 4 AstrocytomasMaher Kurdi, Yousef Katib, Eyad Faizo, et al.
Cancers|February 4, 2021
Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative ReviewAhmad Chaddad, Michael J Kucharczyk, Abbas Cheddad, et al.
Cureus|January 30, 2023
Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center StudyAmber Hassan, Shadi Alahmadi, Omer Waqas, et al.
Pathology, Research and Practice|January 19, 2024
The effect of p53 on the activity of NRF2 and NDRG2 genes through apoptotic pathway in IDH-wildtype glioblastomaMaher Kurdi, Saleh Baeesa, Motaz M Fadul, et al.
Folia Neuropathologica|August 11, 2022
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinomaRiffat Mehboob, Maher Kurdi, Saleh Baeesa, et al.
Journal of Neuro-Oncology|July 4, 2023
Dynamic interplay between corticosteroid treatment and the role of SRC-1 gene dysregulation in the progression of WHO-Grade 4 AstrocytomaMaher Kurdi, Motaz M Fadul, Bassam M J Addas, et al.
Pathology, Research and Practice|September 19, 2023
Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failureNadeem S Butt, Maher Kurdi, Motaz M Fadul, et al.
Pageof 2